View in EDS HTML Full Text PDF Full Text

Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab.
Authors: Takai, Satoshi1 (AUTHOR), Nishida, Hayato1 (AUTHOR) hnishida331@yahoo.co.jp, Ito, Hiromi1 (AUTHOR), Fukuhara, Hiroki1 (AUTHOR), Nawano, Takaaki2 (AUTHOR), Narisawa, Takafumi1 (AUTHOR), Kanno, Hidenori1 (AUTHOR), Yagi, Mayu1 (AUTHOR), Yamagishi, Atsushi1 (AUTHOR), Sakurai, Toshihiko1 (AUTHOR), Naito, Sei1 (AUTHOR), Kato, Tomoyuki1 (AUTHOR), Morikane, Keita3 (AUTHOR), Tsuchiya, Norihiko1 (AUTHOR)
Source: International Journal of Urology. Nov2022, Vol. 29 Issue 11, p1279-1286. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09198172
DOI:10.1111/iju.14978